Managed Healthcare Executive February 22, 2024
Logan Lutton

Because of expensive specialty drugs, pharmacy expenditures accounted for one-quarter of healthcare spending by public sector health plans, according to a new report by two public sector health plan groups.

Specialty drug prescriptions and costs are on the rise in the United States and accounted for over two-thirds of new FDA approvals in the past three years.

To understand how public health sector plans are tackling rising pharmaceutical costs, the Public Sector HealthCare Roundtable and the National Institute for Public Employee Healthcare Policy collaborated on the 2023 Specialty Drug Survey and published a report of their findings this week.

Researchers gathered data from 21 plan sponsors across 16 states representing over 157 health plans for the 2021-2022 plan year.

Around...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Insurance, Pharma, Pharma / Biotech, Pricing / Spending, Survey / Study, Trends
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Redesigning Integrated Care For Dually Eligible People With Intellectual/Developmental Disabilities
Fate of ACA Preventive Services Uncertain Before Supreme Court
Mapped: The Top Health Insurance Companies by State
Mark Farrah Assessed Third Quarter Health Insurance Segment Membership Trends

Share This Article